Search | Page 28 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... a system called CliniMACS to remove Tcells from blood stem cells . Removing T-cells may help stop a side effect called ... correctable by transplant for which CD34+ selected, T-cell depleted allogeneic hematopoietic stem cell transplantation is indicated ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  2. Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerou

    ... safety of nonmyeloablative conditioning and hematopoietic cell transplantation (HCT) from human leukocyte antigen ( HLA ... Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Undergo allogeneic bone marrow transplantation ...

    Clinical Trial last updated 04/26/2016 - 2:09pm.

  3. Clinical Trials Report for April 2014

    ... anemia who need treatment for significantly low blood cell counts. National Institutes of Health Clinical Center ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ...

    Page last updated 04/18/2014 - 3:36pm.

  4. Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

    ... guideline for HLA -Haploidentical hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) ...

    Clinical Trial last updated 06/06/2016 - 10:54am.

  5. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... cells that can be given with chemotherapy and a stem cell transplant to patients with AML and MDS. Researchers want to learn if ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  6. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... strategies to augment the well documented effect of NK cell alloreactivity seen in HLA -mismatched transplantation. These ... reconstitution following haploidentical peripheral blood stem cell transplantation. Patients will receive a nonmyeloablative ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  7. BMT Meant 'It Could Finally Be Over '

    ... 2013, the beginning of my senior year, my red blood cell counts dropped dramatically. I had to get my first red blood cell ... and Beyond In January 2014, I received a stem cell transplant from an unrelated donor . My transplant ended ...

    Patient Chronicle last updated 05/10/2016 - 3:28pm.

  8. Pathogenesis of MDS: An overview of molecular and non-molecular aspects of the disease

    ... are curative.  The only potential curative therapy is a stem cell transplant .  It is known that genetic/chromosomal instability can ...

    Research Review last updated 05/02/2016 - 9:14am.

  9. Recurrent and Secondary MDS

    ... after medical treatments, and even after an allogeneic stem cell transplant . So, I think of recurrent MDS to mean progression or ...

    Interview last updated 10/24/2012 - 1:12pm.

  10. Chicago (IL) LLS BMT Support Group

    Post- Stem Cell Transplant Support Group Northwestern Memorial-Galter Pavilion 201 E. ...

    Group last updated 05/02/2016 - 1:07pm.